Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Isolation of the Dot/Icm Type IV Secretion System Core Complex from Legionella pneumophila.

Kubori T, Nagai H.

Methods Mol Biol. 2019;1921:241-247. doi: 10.1007/978-1-4939-9048-1_15.

PMID:
30694496
2.

Emerging insights into bacterial deubiquitinases.

Kubori T, Kitao T, Nagai H.

Curr Opin Microbiol. 2019 Feb;47:14-19. doi: 10.1016/j.mib.2018.10.001. Epub 2018 Nov 2. Review.

PMID:
30391778
3.

LotA, a Legionella deubiquitinase, has dual catalytic activity and contributes to intracellular growth.

Kubori T, Kitao T, Ando H, Nagai H.

Cell Microbiol. 2018 Jul;20(7):e12840. doi: 10.1111/cmi.12840. Epub 2018 Apr 6.

PMID:
29543380
4.

Legionella RavZ Plays a Role in Preventing Ubiquitin Recruitment to Bacteria-Containing Vacuoles.

Kubori T, Bui XT, Hubber A, Nagai H.

Front Cell Infect Microbiol. 2017 Aug 28;7:384. doi: 10.3389/fcimb.2017.00384. eCollection 2017.

5.

Bacterial secretion system skews the fate of Legionella-containing vacuoles towards LC3-associated phagocytosis.

Hubber A, Kubori T, Coban C, Matsuzawa T, Ogawa M, Kawabata T, Yoshimori T, Nagai H.

Sci Rep. 2017 Mar 20;7:44795. doi: 10.1038/srep44795.

6.

Subversion of Host Membrane Dynamics by the Legionella Dot/Icm Type IV Secretion System.

Hilbi H, Nagai H, Kubori T, Roy CR.

Curr Top Microbiol Immunol. 2017;413:221-242. doi: 10.1007/978-3-319-75241-9_9.

PMID:
29536361
7.

Microbially cleaved immunoglobulins are sensed by the innate immune receptor LILRA2.

Hirayasu K, Saito F, Suenaga T, Shida K, Arase N, Oikawa K, Yamaoka T, Murota H, Chibana H, Nakagawa I, Kubori T, Nagai H, Nakamaru Y, Katayama I, Colonna M, Arase H.

Nat Microbiol. 2016 Apr 25;1(6):16054. doi: 10.1038/nmicrobiol.2016.54.

PMID:
27572839
8.

Life with Bacterial Secretion Systems.

Kubori T.

PLoS Pathog. 2016 Aug 11;12(8):e1005562. doi: 10.1371/journal.ppat.1005562. eCollection 2016 Aug. No abstract available.

9.

The Type IVB secretion system: an enigmatic chimera.

Kubori T, Nagai H.

Curr Opin Microbiol. 2016 Feb;29:22-9. doi: 10.1016/j.mib.2015.10.001. Epub 2015 Oct 31. Review.

PMID:
26529574
10.

Molecular and structural analysis of Legionella DotI gives insights into an inner membrane complex essential for type IV secretion.

Kuroda T, Kubori T, Thanh Bui X, Hyakutake A, Uchida Y, Imada K, Nagai H.

Sci Rep. 2015 Jun 3;5:10912. doi: 10.1038/srep10912.

11.

Hijacking the host proteasome for the temporal degradation of bacterial effectors.

Kubori T, Hubber AM, Nagai H.

Methods Mol Biol. 2014;1197:141-52. doi: 10.1007/978-1-4939-1261-2_8.

PMID:
25172279
12.

Native structure of a type IV secretion system core complex essential for Legionella pathogenesis.

Kubori T, Koike M, Bui XT, Higaki S, Aizawa S, Nagai H.

Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):11804-9. doi: 10.1073/pnas.1404506111. Epub 2014 Jul 25.

13.

Modulation of the ubiquitination machinery by Legionella.

Hubber A, Kubori T, Nagai H.

Curr Top Microbiol Immunol. 2013;376:227-47. doi: 10.1007/82_2013_343. Review.

PMID:
23918174
14.

Purification and characterization of legionella U-box-type E3 ubiquitin ligase.

Nagai H, Kubori T.

Methods Mol Biol. 2013;954:347-54. doi: 10.1007/978-1-62703-161-5_21.

PMID:
23150407
15.

Bacterial effector-involved temporal and spatial regulation by hijack of the host ubiquitin pathway.

Kubori T, Nagai H.

Front Microbiol. 2011 Jul 4;2:145. doi: 10.3389/fmicb.2011.00145. eCollection 2011.

16.

Type IVB Secretion Systems of Legionella and Other Gram-Negative Bacteria.

Nagai H, Kubori T.

Front Microbiol. 2011 Jun 27;2:136. doi: 10.3389/fmicb.2011.00136. eCollection 2011.

17.

[A case of optic neuritis associated with lymphocytic hypophysitis revealed by pattern-reversal VEP].

Saito S, Mori C, Toma K, Kubori T, Nishinaka K, Udaka F.

Rinsho Shinkeigaku. 2011 Jan;51(1):27-31. Japanese.

PMID:
21387696
18.

Legionella metaeffector exploits host proteasome to temporally regulate cognate effector.

Kubori T, Shinzawa N, Kanuka H, Nagai H.

PLoS Pathog. 2010 Dec 2;6(12):e1001216. doi: 10.1371/journal.ppat.1001216.

19.

Crystal structure of Legionella DotD: insights into the relationship between type IVB and type II/III secretion systems.

Nakano N, Kubori T, Kinoshita M, Imada K, Nagai H.

PLoS Pathog. 2010 Oct 7;6(10):e1001129. doi: 10.1371/journal.ppat.1001129.

20.

Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions.

Kubori T, Hyakutake A, Nagai H.

Mol Microbiol. 2008 Mar;67(6):1307-19. doi: 10.1111/j.1365-2958.2008.06124.x. Epub 2008 Feb 13.

21.

Thalamic hyperperfusion in verbal hallucination of Parkinsonian patients.

Matsui H, Nishinaka K, Miyoshi T, Hara N, Oda M, Kubori T, Udaka F.

Intern Med. 2007;46(21):1765-9. Epub 2007 Nov 1.

22.

Dementia in Parkinson's disease: diffusion tensor imaging.

Matsui H, Nishinaka K, Oda M, Niikawa H, Kubori T, Udaka F.

Acta Neurol Scand. 2007 Sep;116(3):177-81.

PMID:
17714331
23.

Depression in Parkinson's disease. Diffusion tensor imaging study.

Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F.

J Neurol. 2007 Sep;254(9):1170-3. Epub 2006 Aug 20.

PMID:
17710361
24.

Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging.

Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F.

Acta Neurol Scand. 2007 Aug;116(2):108-12.

PMID:
17661796
25.

Trousseau syndrome due to pleural mesothelioma.

Matsui H, Nishinaka K, Oda M, Kubori T, Udaka F.

Neurologist. 2007 Jul;13(4):205-8.

PMID:
17622912
26.

Auditory event-related potentials in Parkinson's disease: prominent correlation with attention.

Matsui H, Nishinaka K, Oda M, Kubori T, Udaka F.

Parkinsonism Relat Disord. 2007 Oct;13(7):394-8. Epub 2007 Feb 27.

PMID:
17329143
27.

Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS.

Asai H, Hirano M, Udaka F, Shimada K, Oda M, Kubori T, Nishinaka K, Tsujimura T, Izumi Y, Konishi N, Matsumoto S, Kameyama M, Ueno S.

J Neurol Sci. 2007 Mar 15;254(1-2):78-83. Epub 2007 Feb 14.

PMID:
17303172
28.

Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study.

Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F.

Parkinsonism Relat Disord. 2007 Apr;13(3):174-81. Epub 2006 Dec 4.

PMID:
17145197
29.

Adult onset hemiparkinsonism with brain hemihypoplasia.

Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F.

Neurol India. 2006 Dec;54(4):450-1. No abstract available.

30.

Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations.

Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F.

Mov Disord. 2006 Dec;21(12):2140-4.

PMID:
17029272
31.

Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.

Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F.

Mov Disord. 2006 Dec;21(12):2165-9.

PMID:
17029260
32.

Excessive daytime sleepiness in Parkinson disease: a SPECT study.

Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F.

Sleep. 2006 Jul;29(7):917-20.

PMID:
16895259
33.

Assembly of the inner rod determines needle length in the type III secretion injectisome.

Marlovits TC, Kubori T, Lara-Tejero M, Thomas D, Unger VM, Galán JE.

Nature. 2006 Jun 1;441(7093):637-40.

PMID:
16738660
34.

Minor depression and brain perfusion images in Parkinson's disease.

Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F.

Mov Disord. 2006 Aug;21(8):1169-74.

PMID:
16685687
35.

Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease.

Matsui H, Udaka F, Oda M, Kubori T, Nishinaka K, Kameyama M.

Neurol India. 2006 Mar;54(1):83-5.

36.

Disruptions of the fornix fiber in Parkinsonian patients with excessive daytime sleepiness.

Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F.

Parkinsonism Relat Disord. 2006 Jun;12(5):319-22. Epub 2006 Apr 18.

PMID:
16621664
37.

A pathway branching in transcription initiation in Escherichia coli.

Susa M, Kubori T, Shimamoto N.

Mol Microbiol. 2006 Mar;59(6):1807-17.

38.

Wisconsin Card Sorting Test and brain perfusion imaging in Parkinson's disease.

Matsui H, Nishinaka K, Oda M, Hara N, Komatsu K, Kubori T, Udaka F.

Parkinsonism Relat Disord. 2006 Jun;12(5):273-8. Epub 2006 Mar 23.

PMID:
16551505
39.

Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?

Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F.

Parkinsonism Relat Disord. 2006 Jun;12(5):284-8. Epub 2006 Mar 23.

PMID:
16549383
40.

HTLV-I-associated peripheral neuropathy with smoldering-type adult T-cell leukemia.

Matsui H, Udaka F, Kubori T, Oda M, Nishinaka K, Oka N.

Neurologist. 2006 Mar;12(2):109-13.

PMID:
16534449
41.

Parkinson's disease following panic disorder.

Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, Kameyama M.

J Neuropsychiatry Clin Neurosci. 2006 Winter;18(1):130. No abstract available.

PMID:
16525084
42.

Frontal assessment battery and brain perfusion image in Parkinson's disease.

Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

J Geriatr Psychiatry Neurol. 2006 Mar;19(1):41-5.

PMID:
16449760
43.

Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.

Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

J Geriatr Psychiatry Neurol. 2006 Mar;19(1):36-40.

PMID:
16449759
44.

N-isopropyl-p- 123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.

Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

Intern Med. 2005 Oct;44(10):1046-50.

45.

Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease.

Asai H, Udaka F, Hirano M, Minami T, Oda M, Kubori T, Nishinaka K, Kameyama M, Ueno S.

Parkinsonism Relat Disord. 2005 Dec;11(8):499-502. Epub 2005 Nov 2.

PMID:
16263322
46.

Multiple sclerosis following splenectomy as a treatment for idiopathic thrombocytopenic purpura.

Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

Intern Med. 2005 Jul;44(7):747-9.

47.

Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease.

Matsui H, Udaka F, Miyoshi T, Hara N, Tamaura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

Mov Disord. 2005 Oct;20(10):1272-7.

PMID:
16007622
48.

Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.

Matsui H, Udaka F, Oda M, Tamura A, Kubori T, Nishinaka K, Kameyama M.

Ann Nucl Med. 2005 May;19(3):225-9.

PMID:
15981676
49.

Persistent primitive hypoglossal artery with atrial septal defect.

Matsui H, Udaka F, Kubori T, Oda M, Nishinaka K, Kameyama M.

Intern Med. 2005 May;44(5):507-8. No abstract available.

50.

Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson's disease.

Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M.

Acta Neurol Scand. 2005 Jul;112(1):36-41.

PMID:
15932354

Supplemental Content

Loading ...
Support Center